Key facts
- Notable investors include CMB International Capital, Xingxiang Investment Holding Group, Huatong Capital, Hunan Guoling Investment, iFlytek.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Qianmu Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Qianmu Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Qianmu Biotechnology
Manufacturer of biotechnology products designed to advance medical and life science applications. The company integrates research, development, and production to deliver innovative biotech solutions that improve healthcare outcomes, support biomedical innovation, and strengthen China's biotechnology industry.
- Sector
- Healthcare
- HQ
- Tianjin, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Qianmu Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Qianmu Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Qianmu Biotechnology in its N-PORT filings yet. We sweep new filings monthly.